The Unique Properties of Placental Mesenchymal Stromal Cells: A Novel Source of Therapy for Congenital and Acquired Spinal Cord Injury
Spinal cord injury (SCI) is a devasting condition with no reliable treatment. Spina bifida is the most common cause of congenital SCI. Cell-based therapies using mesenchymal stem/stromal cells (MSCS) have been largely utilized in SCI. Several clinical trials for acquired SCI use adult tissue-derived...
Main Authors: | Edwin S Kulubya, Kaitlin Clark, Dake Hao, Sabrina Lazar, Arash Ghaffari-Rafi, Tejas Karnati, Julius Okudu Ebinu, Marike Zwienenberg, Diana L Farmer, Aijun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/11/2837 |
Similar Items
-
Long-term follow-up of keystone perforator island flap in reconstructed myelomeningocele defects
by: Tetyana Kelly, et al.
Published: (2023-12-01) -
Fetoscopic Myelomeningocele Repair with Complete Release of the Tethered Spinal Cord Using a Three-Port Technique: Twelve-Month Follow-Up—A Case Report
by: Agnieszka Pastuszka, et al.
Published: (2022-11-01) -
Sexuality of Female Spina Bifida Patients: Predictors of a Satisfactory Sexual Function
by: Guilherme Lang Motta, et al.
Published: (2021-09-01) -
Intellectual characteristics using WISC-IV in children with myelomeningocele
by: Hiroshi Mano, et al.
Published: (2018-01-01) -
Kyphectomy and sliding growing rod technique in patients with congenital lumbar kyphosis deformity with myelomeningocele
by: Muhammed Enes Karataş, et al.
Published: (2024-02-01)